225 reports of this reaction
1.4% of all TESTOSTERONE CYPIONATE reports
#20 most reported adverse reaction
CARDIOVASCULAR DISORDER is the #20 most commonly reported adverse reaction for TESTOSTERONE CYPIONATE, manufactured by Pharmacia & Upjohn Company LLC. There are 225 FDA adverse event reports linking TESTOSTERONE CYPIONATE to CARDIOVASCULAR DISORDER. This represents approximately 1.4% of all 15,890 adverse event reports for this drug.
TESTOSTERONE CYPIONATE has an overall safety score of 85 out of 100. Patients taking TESTOSTERONE CYPIONATE who experience cardiovascular disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIOVASCULAR DISORDER is a less commonly reported adverse event for TESTOSTERONE CYPIONATE, but still significant enough to appear in the safety profile.
In addition to cardiovascular disorder, the following adverse reactions have been reported for TESTOSTERONE CYPIONATE:
CARDIOVASCULAR DISORDER has been reported as an adverse event in 225 FDA reports for TESTOSTERONE CYPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIOVASCULAR DISORDER accounts for approximately 1.4% of all adverse event reports for TESTOSTERONE CYPIONATE, making it a notable side effect.
If you experience cardiovascular disorder while taking TESTOSTERONE CYPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.